Analyst coverage

Texas Instruments is covered by the following analysts.

Firm Analyst
Arete Research Services, LLP Dan Gardiner
Cleaveland Research Company Kevin Rottinghouse
Davenport & Company Drake Johnstone
Evercore ISI Group CJ Muse
Mizuho Vijay Rakesh
Argus Research Company Jim Kelleher
Ascendiant Capital Cody Acree
B. Riley & Co, LLC Craig Ellis
Barclays Capital, Inc Blayne Curtis
BMO Capital Markets-US Ambrish Srivastava
BOFA Merrill Lynch (US) Vivek Arya
Charter Equity Research Edward Snyder
Citi Investment Research (US) Chris Danley
CLSA Srini Pajjuri
Cowen & Co, LLC Timothy Arcuri
Credit Suisse Securities (USA), LLC John Pitzer
Deutsche Bank Securities, Inc Ross Seymore
Exane BNP Paribas (UK) Jerome Ramel
FBR Capital Markets & Co Christopher Rolland
Goldman Sachs & Company, Inc James Covello
Jefferies & Company, Inc Mark Lipacis
JP Morgan Securities, Inc Harlan Sur
Macquarie Capital (USA), Inc Deepon Nag
MKM Partners, LLC Ian Ing
Morgan Stanley & Co, LLC Joseph Moore
Morningstar, Inc Brian Colello
Nomura Securities International, Inc Romit Shah
Oppenheimer & Co, Inc Rick Schafer
Pacific Crest Securities, Inc Michael McConnell
Raymond James & Associates, Inc Steve Smigie
RBC Capital Markets Wealth Management Amit Daryanani
Robert W. Baird & Co, Inc Tristan Gerra
Sanford C. Bernstein & Co, LLC Stacy Rasgon
Stifel Nicolaus Weisel Tore Svanberg
Sun Trust Robinson Humphrey, Inc William Stein
Susquehanna Financial Group, LLLP Chris Caso
UBS Securities, LLC Stephen Chin
Wedbush Securities, Inc Betsy Van Hees
Wells Fargo Securities, LLC David Wong

Texas Instruments Incorporated is currently followed by the analysts listed above. Brokerage firms may decide at any time to terminate or commence coverage of Texas Instruments stock. Please note that any opinions, estimates or forecasts regarding Texas Instruments Incorporated's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Texas Instruments Incorporated or its management. Texas Instruments Incorporated does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.